BioLineRx (BLRX) Debt Ratio (2011 - 2025)

BioLineRx's Debt Ratio history runs 12 years deep, the most recent figure standing at 0.22 for Q4 2025.

• On a quarterly basis, Debt Ratio fell 36.73% year-over-year to 0.22 in Q4 2025; TTM through Dec 2025 was 0.22, a 36.73% decrease from a year earlier, with the FY2025 full-year figure at 0.22, down 36.73% from the prior year.
• Debt Ratio slipped to 0.22 in Q4 2025 per BLRX's latest filing, from 0.25 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.53 in Q3 2024 and bottomed at 0.01 in Q2 2022.
• The 5-year median for Debt Ratio is 0.17 (2024), against an average of 0.19.
• Across the five-year window, Debt Ratio sank 72.53% in 2021 and soared 1215.01% in 2023, its largest moves.
• Year by year, Debt Ratio stood at 0.03 in 2021, then jumped by 292.98% to 0.13 in 2022, then increased by 14.85% to 0.15 in 2023, then surged by 125.91% to 0.35 in 2024, then tumbled by 36.73% to 0.22 in 2025.
• Per Business Quant, the three latest BLRX Debt Ratio figures stand at 0.22 (Q4 2025), 0.25 (Q3 2025), and 0.26 (Q2 2025).